Women's Health Issues
Volume 18, Issue 4 , Pages 226-228, July 2008

An Innovative Approach to Determine Fetal Risk:

The FDA Office of Women's Health Pregnancy Exposure Registry Web Listing

  • Pellavi Sharma, MPH

      Affiliations

    • Corresponding Author InformationCorrespondence to: Pellavi Sharma, MPH, 5600 Fisher's Lane, Parklawn Building, Room 16-6 HF-8, Rockville, MD 20857.
    • Pellavi Sharma, MPH, is an ORISE Research Fellow with the FDA Office of Women's Health.
    • ,
  • Ameeta Parekh, PhD

      Affiliations

    • Ameeta Parekh, PhD, is Director of the Research and Development Program in the Office of Women's Health. The office of Women's Health Mission is to protect and advance the health of women through policy, science and outreach and to advocate for the participation of women in clinical trials for sex, gender and subpopulation analyses.
    • ,
  • Kathleen Uhl, MD

      Affiliations

    • Kathleen Uhl, MD, is the Assistant Commissioner for Women's Health at the Food and Drug Administration.

Food and Drug Administration, Office of Women's Health, Rockville, Maryland

Received 21 September 2007; accepted 20 February 2008. published online 13 May 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1049-3867(08)00033-9

doi:10.1016/j.whi.2008.02.006

Women's Health Issues
Volume 18, Issue 4 , Pages 226-228, July 2008

Article Tools